BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16914641)

  • 1. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
    Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
    Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abi-1 forms an epidermal growth factor-inducible complex with Cbl: role in receptor endocytosis.
    Tanos BE; Pendergast AM
    Cell Signal; 2007 Jul; 19(7):1602-9. PubMed ID: 17395426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling.
    Fallon L; Bélanger CM; Corera AT; Kontogiannea M; Regan-Klapisz E; Moreau F; Voortman J; Haber M; Rouleau G; Thorarinsdottir T; Brice A; van Bergen En Henegouwen PM; Fon EA
    Nat Cell Biol; 2006 Aug; 8(8):834-42. PubMed ID: 16862145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.
    Okur MN; Russo A; O'Bryan JP
    Mol Cell Biol; 2014 Jan; 34(2):271-9. PubMed ID: 24216759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ubiquitination-mediated degradation of epidermal growth factor receptor].
    Xiu X; Lü ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):120-7. PubMed ID: 15782507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway.
    Das M; Scappini E; Martin NP; Wong KA; Dunn S; Chen YJ; Miller SL; Domin J; O'Bryan JP
    Mol Cell Biol; 2007 Nov; 27(22):7906-17. PubMed ID: 17875942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.
    Okur MN; Ooi J; Fong CW; Martinez N; Garcia-Dominguez C; Rojas JM; Guy G; O'Bryan JP
    Mol Cell Biol; 2012 Feb; 32(4):817-25. PubMed ID: 22158968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase.
    Scappini E; Koh TW; Martin NP; O'Bryan JP
    Hum Mol Genet; 2007 Aug; 16(15):1862-71. PubMed ID: 17550941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intersectin 1 forms a complex with adaptor protein Ruk/CIN85 in vivo independently of epidermal growth factor stimulation.
    Nikolaienko O; Skrypkina I; Tsyba L; Fedyshyn Y; Morderer D; Buchman V; de la Luna S; Drobot L; Rynditch A
    Cell Signal; 2009 May; 21(5):753-9. PubMed ID: 19166927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
    Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
    Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac1-mediated cytoskeleton rearrangements induced by intersectin-1s deficiency promotes lung cancer cell proliferation, migration and metastasis.
    Jeganathan N; Predescu D; Zhang J; Sha F; Bardita C; Patel M; Wood S; Borgia JA; Balk RA; Predescu S
    Mol Cancer; 2016 Sep; 15(1):59. PubMed ID: 27629044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.
    Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I
    J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.
    Shen F; Lin Q; Gu Y; Childress C; Yang W
    Mol Biol Cell; 2007 Mar; 18(3):732-42. PubMed ID: 17182860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHIP2 associates with intersectin and recruits it to the plasma membrane in response to EGF.
    Xie J; Vandenbroere I; Pirson I
    FEBS Lett; 2008 Sep; 582(20):3011-7. PubMed ID: 18692052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met.
    Petrelli A; Gilestro GF; Lanzardo S; Comoglio PM; Migone N; Giordano S
    Nature; 2002 Mar; 416(6877):187-90. PubMed ID: 11894096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis.
    Huang F; Sorkin A
    Mol Biol Cell; 2005 Mar; 16(3):1268-81. PubMed ID: 15635092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ShcD phosphotyrosine adaptor subverts canonical EGF receptor trafficking.
    Wills MKB; Lau HR; Jones N
    J Cell Sci; 2017 Sep; 130(17):2808-2820. PubMed ID: 28724758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix.
    Schmidt MHH; Husnjak K; Szymkiewicz I; Haglund K; Dikic I
    Oncogene; 2006 May; 25(21):3071-8. PubMed ID: 16407834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
    Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
    Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling.
    Waterman H; Katz M; Rubin C; Shtiegman K; Lavi S; Elson A; Jovin T; Yarden Y
    EMBO J; 2002 Feb; 21(3):303-13. PubMed ID: 11823423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.